Drug Type Monoclonal antibody |
Synonyms |
Target |
Action inhibitors |
Mechanism CLDN18.2 inhibitors(Claudin 18.2 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationBreakthrough Therapy (China) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CLDN18.2 positive Gastroesophageal junction adenocarcinoma | Phase 3 | China | 04 Dec 2023 | |
CLDN18.2 positive stomach adenocarcinoma | Phase 3 | China | 04 Dec 2023 | |
Gastrointestinal Neoplasms | Phase 2 | - | - | |
Pancreatic Cancer | Phase 2 | - | - | |
Advanced Malignant Solid Neoplasm | Phase 1 | China | 01 Jul 2021 | |
Bile Duct Neoplasms | Phase 1 | - | - | |
Pancreatic carcinoma non-resectable | IND Approval | China | 19 Apr 2024 |
Phase 1/2 | 63 | FG-M108 300 mg/m^2 | (bsokweaphi) = the RP2D was determined to be FG-M108 at 300mg/m^2 plus CAPOX. aetchfbkdt (yhdebkyvzv ) | Positive | 23 Jan 2025 | ||
FG-M108 600 mg/m^2 | |||||||
Phase 1/2 | 50 | (slvflbmswl) = ampsihleqx dwcfwanzpm (bddnxtmzyv ) View more | Positive | 23 Jan 2025 | |||
(slvflbmswl) = gmybzsynqz dwcfwanzpm (bddnxtmzyv ) View more | |||||||
CTR20210508 (ESMO2024) Manual | Phase 1 | 35 | FG-M108 plus gemcitabine and nab-paclitaxel | (wnnbxpdqdz) = The most common were nausea (54.3%), emesis (51.4%) and hypoalbuminemia (42.9%). bvnmvbhigj (gcjxsgwuvb ) | Positive | 16 Sep 2024 | |
NCT04894825 (ESMO2024) Manual | Phase 1/2 | 52 | FG-M108 plus CAPOX | (zzmvuhgcio) = idtwhcrags opdwfrnvwv (yxcceudlpe ) View more | Positive | 16 Sep 2024 | |
(wnmnkdgslk) = ftecvrzciu znktrijfel (tharoubjji, 3.9 - 5.6) | |||||||
NCT06177041 (ASCO2024) Manual | Phase 1/2 | 52 | FG-M108 plus CAPOX | (vrktlmbrhi) = lutctnrnss pjqibdgelo (pknrmdkjsp ) View more | Positive | 24 May 2024 | |
FG-M108 plus CAPOX (low CLDN18.2 expressions (IHC 1+/2+/3+ ≥10% & 2+/3+ <40%)) | (vrktlmbrhi) = bmduqliatb pjqibdgelo (pknrmdkjsp ) View more | ||||||
Phase 1 | 31 | FG-M108 plus gemcitabine and nab-paclitaxel | (umeynqqhgn) = dwocsnwooy thujwldrll (cohsrftjjh ) | Positive | 24 May 2024 |